News

2015 Nov 06

DIPG: Searching for a Cure

A new procedure by Mark Souweidane, M.D., that uses special catheters to bypass the blood-brain barrier could revolutionize treatment for diffuse intrinsic pontine glioma and other pediatric brain cancers. Read more

2015 Nov 05

Has research lost its way?

Harold Varmus, M.D., reflects on the state of research competition and funding. Read more

2015 Nov 05

New drug combination suggests promising treatment for mantle cell lymphoma

Lenalidomide, taken in combination with the antibody Rituximab, provides an effective alternative to chemotherapy, according to findings by Jia Ruan, M.D., Ph.D., John Leonard, M.D., and colleagues. Read more

2015 Nov 05

Vitamin C halts growth of aggressive forms of colorectal cancer in preclinical study

High levels of vitamin C kill colorectal cancers with KRAS and BRAF mutations in cell cultures and mice, according to a new study from Lewis Cantley, Ph.D. Read more

2015 Nov 04

Novel antibodies could revolutionize treatment for relapsed ALL

Coverage of a presentation by Gail Roboz, M.D., at the 33rd Annual Chemotherapy Foundation Symposium Read more

2015 Nov 03

New type of cancer treatment targets proteins in cancer cells

The lab of Ari Melnick, M.D., has developed a new combination Hsp90 inhibition therapy to target diffuse large B-cell lymphoma. Read more

2015 Nov 02

New layer of gene regulation may play key role in common lymphoma

A team of investigators led by Olivier Elemento, Ph.D., has discovered thousands of new genes in 116 human samples of lymphoma. Read more

2015 Nov 02

Genome sequencing of tumors are helping pathologist and physicians identify useful therapies for patients with unresponsive cancers

A recent study by Himisha Beltran, M.D., is highlighted as an example of the promise of precision medicine. Read more

2015 Oct 28

Targeting epigenetic switches may lead to novel therapies for B-cell lymphomas

Coverage of a presentation by Ari Melnick, M.D., at the recent Lymphoma & Myeloma 2015 meeting which featured many Weill Cornell organizers and investigators. Read more

2015 Oct 28

Cell stress response and fat and obesity gene linked

Samie Jaffrey and colleagues have discovered mechanisms that control the function of a fat and obesity gene while also answering a long-standing question about how cells respond to stress. Read more

2015 Oct 28

Tumor exosome protein signatures predict future organ sites of cancer spread

Findings by David Lyden and colleagues support Paget's "seed and soil" theory of metastasis Read more

2015 Oct 28

Clinical, molecular characteristics predict Richter’s syndrome risk factors, outcomes

Coverage of the recent Lymphoma & Myeloma 2015 meeting which featured many Weill Cornell organizers and investigators Read more

Photo of Christopher Barbieri, M.D., Ph.D.

2015 Oct 27

Prostate cancer: SPOP the mutation

Christopher Barbieri and colleagues shed light on why prostate tumors with a mutation in a gene called SPOP have a high rearrangement frequency Read more

Former pediatric cancer patient Frank Paternoster

2015 Oct 27

Second Chance : A Life After Cancer

After surviving pediatric cancer, Frank Paternoster and his family share his deeply moving story. Read more

2015 Oct 27

Prigerson named as NCI Outstanding Investigator

Holly G. Prigerson, Ph.D has been named as a recipient of the NCI Outstanding Investigator Award for her end-of-life care research Read more

2015 Oct 25

Hodgkin lymphoma: Frontline brentuximab monotherapy promising for elderly patients

John P. Leonard, M.D., comments on a single-agent treatment for older patients with Hodgkin lymphoma. Read more

2015 Oct 23

New knowledge of how diseased cells make proteins may have applications to cancer research

Findings from the lab of Samie Jaffrey, Ph.D., about cap-independent translation in the mRNA of diseased cells IDs a novel pathway that could become a therapeutic target. Read more

2015 Oct 22

New insights into telomeres may have implications for cancer therapy

A team led by Neal Lue has discovered vulnerabilities in the ALT pathway that investigators might be able to harness for new targeted cancer therapies. Read more

2015 Oct 22

3-D organoids allow tests of lymphoma treatments

Leandro Cerchetti, Ari Melnick and Ithaca collaborators have created a revolutionary new model to study lymphoma. Read more

2015 Oct 22

Cantley team uncovers vulnerability that can be exploited to kill lung cancer cells

The Cantley lab has gained insight into how alterations in a key metabolic pathway drive non-small cell lung cancers and lead to poor prognosis in its patients. Read more

News

DIPG: Searching for a Cure

Has research lost its way?

New drug combination suggests promising treatment for mantle cell lymphoma

Vitamin C halts growth of aggressive forms of colorectal cancer in preclinical study

Novel antibodies could revolutionize treatment for relapsed ALL

New type of cancer treatment targets proteins in cancer cells

New layer of gene regulation may play key role in common lymphoma

Genome sequencing of tumors are helping pathologist and physicians identify useful therapies for patients with unresponsive cancers

Targeting epigenetic switches may lead to novel therapies for B-cell lymphomas

Cell stress response and fat and obesity gene linked

Tumor exosome protein signatures predict future organ sites of cancer spread

Clinical, molecular characteristics predict Richter’s syndrome risk factors, outcomes

Prostate cancer: SPOP the mutation

Second Chance : A Life After Cancer

Prigerson named as NCI Outstanding Investigator

Hodgkin lymphoma: Frontline brentuximab monotherapy promising for elderly patients

New knowledge of how diseased cells make proteins may have applications to cancer research

New insights into telomeres may have implications for cancer therapy

3-D organoids allow tests of lymphoma treatments

Cantley team uncovers vulnerability that can be exploited to kill lung cancer cells

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters